LANCE: Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy
Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC)
Sponsor: Conquer Cancer Foundation of the American Society of Clinical Oncology and DOD
Enrolling: Female Patients Only
IRB Number: AAAT3353
Contact: Reena Vattakalam: 212-342-6895 /
Additional Study Information: The goal of this clinical research study is to compare the outcomes of minimally invasive surgery (the investigational surgery) to laparotomy (the current standard of care) in women with Epithelial Ovarian Cancer (EOC) who receive chemotherapy before and after surgery. Researchers want to learn if one surgery can prevent the disease from returning for longer and/or improve your quality of life after surgery. Both the minimally invasive surgery and laparotomy procedures in this study are performed using FDA-approved and commercially available methods. It is considered investigational to compare the outcomes of these methods when used to treat advanced EOC in women who have responded to neoadjuvant chemotherapy.
Jason Wright, MD
Do You Qualify?
Have you been diagnosed with stage 3 or 4 ovarian, fallopian tube or primary peritoneal cancer? Yes No
Have you received chemotherapy? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Reena Vattakalam